COVID-19 Vaccination Is Needed in Patients With Cancer to Enable Optimal Treatment Delivery

home / oncclub / covid-19-vaccination-is-needed-in-patients-with-cancer-to-enable-optimal-treatment-delivery

Balazs Halmos, MD, discusses findings from a study he participated on, which found that COVID-19 vaccination induced high rates of seroconversion in patients with cancer, although those with hematologic malignancies had lower immunogenicity and those who received prior immunosuppressive therapies appeared to be less responsive.

Halmos Highlights Effort Exploring COVID-19 Vaccines in Patients With Cancer

Halmos Highlights Effort Exploring COVID-19 Vaccines in Patients With Cancer

June 24th 2021

Dr. Halmos discusses the data from a study examining seroconversion rates following COVID-19 vaccination among patients with cancer and underscores the need for novel vaccination or passive immunization strategies for immunosuppressed cohorts.

Balazs Halmos, MD

Dr. Halmos on the Efficacy of COVID-19 Vaccines in Patients With Cancer

June 25th 2021

Balazs Halmos, MD, discusses the efficacy of the COVID-19 vaccines in patients with cancer.

Balazs Halmos, MD, MS

COVID-19 Vaccination Induces High Seroconversion Rates in Patients With Cancer, But Novel Strategies Needed for Select Subsets

July 8th 2021

Balazs Halmos, MD, MS, discusses a study examining the effectiveness of COVID-19 vaccination in patients with cancer and identified important areas for future research.

Balazs Halmos, MD, MS

Study Calls for COVID-19 Vaccination in Patients With Cancer to Enable Optimal Treatment Delivery During Pandemic

August 16th 2021

COVID-19 vaccination has been shown to induce high rates of seroconversion in patients with cancer, although those with hematologic malignancies have demonstrated lower immunogenicity and those who previously received immunosuppressive therapies appear to be less responsive.